RBF Capital’s Mural Oncology MURA Stock Holding History

RBF Capital’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-283,912	Closed	-$588K	–	591
2025 Q3	$588K	Hold	283,912	–	–	0.03%	386
2025 Q2	$701K	Sell	283,912 -32,262	-10%	-$76K	0.03%	368
2025 Q1	$398K	Sell	316,174 -22,495	-7%	-$82K	0.02%	420
2024 Q4	$1.09M	Sell	338,669 -21,231	-6%	-$74.9K	0.06%	281
2024 Q3	$1.13M	Sell	359,900 -28,234	-7%	-$91.9K	0.06%	278
2024 Q2	$1.22M	Buy	+388,134	New	+$1.43M	0.07%	251

RBF Capital's MURA Position: Q4 2025 in Review

RBF Capital sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 283,912 shares — an estimated $588K sold.

RBF Capital first reported a position in MURA in Q2 2024 and held it in 6 quarters. The position peaked at $1.22M in Q2 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

RBF Capital reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
RBF Capital sold 283,912 Mural Oncology shares in Q4 2025, an estimated $588K.
RBF Capital first reported a position in Mural Oncology in Q2 2024 and held it in 6 quarters.
RBF Capital's Mural Oncology position peaked at $1.22M in Q2 2024.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on RBF Capital's 13F filing for Q4 2025, filed 17 Feb 2026.